• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

α-1抗胰蛋白酶缺乏症相关慢性阻塞性肺疾病:家庭视角

Alpha-1 Antitrypsin Deficiency-Associated Chronic Obstructive Pulmonary Disease: A Family Perspective.

作者信息

Anzueto Antonio

机构信息

a South Texas Veterans Health Care System, Audie L. Murphy Hospital, and University of Texas Health Science Center , San Antonio , Texas , USA.

出版信息

COPD. 2015 Aug;12(4):462-7. doi: 10.3109/15412555.2014.974746.

DOI:10.3109/15412555.2014.974746
PMID:25474273
Abstract

Alpha-1 antitrypsin (AAT) deficiency (AATD) is a genetic condition that can lead to the early onset of chronic obstructive pulmonary disease (COPD), a disorder that comprises elements of chronic bronchitis and emphysema. AATD is characterized by reduced levels of the AAT protease inhibitor, leading to unrestricted protease activity in the lung, which promotes destruction of lung tissue. In severe cases, patients with AATD have an increased mortality risk and, potentially, a poor quality of life due to more frequent COPD exacerbations and/or limitations on daily activity. However, the burden of AATD on members of the patient's immediate family who may serve as caregivers has not been described. Because the age range at which most patients are diagnosed with AATD may affect the economic status of an individual and/or of a family, it is likely that a diagnosis of AATD may have negative effects that extend beyond those on the diagnosed person to include immediate family members. Here, we review the literature to investigate the impact of the caregiver role of family members in disease states that affect an age group similar to AATD. Furthermore, we provide a case study showing the effect of AATD on immediate family members.

摘要

α-1抗胰蛋白酶(AAT)缺乏症(AATD)是一种遗传性疾病,可导致慢性阻塞性肺疾病(COPD)提前发病,COPD是一种包含慢性支气管炎和肺气肿成分的疾病。AATD的特征是AAT蛋白酶抑制剂水平降低,导致肺部蛋白酶活性不受限制,从而促进肺组织破坏。在严重情况下,AATD患者的死亡风险增加,并且由于COPD更频繁发作和/或日常活动受限,其生活质量可能较差。然而,尚未描述AATD对可能担任照顾者的患者直系亲属的影响。由于大多数患者被诊断出患有AATD的年龄范围可能会影响个人和/或家庭的经济状况,因此AATD的诊断可能产生的负面影响可能不仅限于被诊断者,还包括直系亲属。在此,我们回顾文献以调查家庭成员的照顾者角色在影响与AATD相似年龄组的疾病状态中的影响。此外,我们提供了一个案例研究,展示了AATD对直系亲属的影响。

相似文献

1
Alpha-1 Antitrypsin Deficiency-Associated Chronic Obstructive Pulmonary Disease: A Family Perspective.α-1抗胰蛋白酶缺乏症相关慢性阻塞性肺疾病:家庭视角
COPD. 2015 Aug;12(4):462-7. doi: 10.3109/15412555.2014.974746.
2
The important role of primary care providers in the detection of alpha-1 antitrypsin deficiency.初级保健提供者在α-1抗胰蛋白酶缺乏症检测中的重要作用。
Postgrad Med. 2017 Nov;129(8):889-895. doi: 10.1080/00325481.2017.1381539. Epub 2017 Oct 5.
3
Indications for active case searches and intravenous alpha-1 antitrypsin treatment for patients with alpha-1 antitrypsin deficiency chronic pulmonary obstructive disease: an update.α-1抗胰蛋白酶缺乏症慢性阻塞性肺疾病患者的主动病例筛查及静脉注射α-1抗胰蛋白酶治疗的指征:最新进展
Arch Bronconeumol. 2015 Apr;51(4):185-92. doi: 10.1016/j.arbres.2014.05.008. Epub 2014 Jul 12.
4
Immune activation in α1-antitrypsin-deficiency emphysema. Beyond the protease-antiprotease paradigm.α1-抗胰蛋白酶缺乏性肺气肿中的免疫激活。超越蛋白酶-抗蛋白酶范式。
Am J Respir Crit Care Med. 2015 Feb 15;191(4):402-9. doi: 10.1164/rccm.201403-0529OC.
5
Costs and health-related quality of life in Alpha-1-Antitrypsin Deficient COPD patients.α-1抗胰蛋白酶缺乏性慢性阻塞性肺疾病患者的成本与健康相关生活质量
Respir Res. 2017 Apr 17;18(1):60. doi: 10.1186/s12931-017-0543-8.
6
Treatment of lung disease in alpha-1 antitrypsin deficiency: a systematic review.α-1抗胰蛋白酶缺乏症所致肺部疾病的治疗:一项系统评价
Int J Chron Obstruct Pulmon Dis. 2017 May 2;12:1295-1308. doi: 10.2147/COPD.S130440. eCollection 2017.
7
PiSZ alpha-1 antitrypsin deficiency (AATD): pulmonary phenotype and prognosis relative to PiZZ AATD and PiMM COPD.PiSZ 型 α-1 抗胰蛋白酶缺乏症(AATD):与 PiZZ 型 AATD 和 PiMM COPD 相比的肺部表型和预后。
Thorax. 2015 Oct;70(10):939-45. doi: 10.1136/thoraxjnl-2015-206906. Epub 2015 Jul 3.
8
Recent advances in understanding and treating COPD related to α-antitrypsin deficiency.与α-抗胰蛋白酶缺乏相关的慢性阻塞性肺疾病(COPD)在认识和治疗方面的最新进展。
Expert Rev Respir Med. 2016 Dec;10(12):1281-1294. doi: 10.1080/17476348.2016.1249851. Epub 2016 Nov 4.
9
The natural history of lung function after lung transplantation for α(1)-antitrypsin deficiency.α(1)-抗胰蛋白酶缺乏症肺移植后肺功能的自然史。
Am J Respir Crit Care Med. 2014 Aug 1;190(3):274-81. doi: 10.1164/rccm.201401-0031OC.
10
Characteristics of Alpha-1 Antitrypsin-Deficient Individuals in the Long-term Oxygen Treatment Trial and Comparison with Other Subjects with Chronic Obstructive Pulmonary Disease.长期氧疗试验中α-1抗胰蛋白酶缺乏个体的特征及其与其他慢性阻塞性肺疾病患者的比较。
Ann Am Thorac Soc. 2015 Dec;12(12):1796-804. doi: 10.1513/AnnalsATS.201506-389OC.

引用本文的文献

1
Patient-centered assessment of treatment for alpha-1 antitrypsin deficiency: literature review to identify concepts and measures for people with alpha1-antitrypsin deficiency.以患者为中心的α-1抗胰蛋白酶缺乏症治疗评估:文献综述以确定α1抗胰蛋白酶缺乏症患者的概念和措施。
Orphanet J Rare Dis. 2025 Feb 22;20(1):83. doi: 10.1186/s13023-025-03592-9.
2
Is It Time Alpha-1 Antitrypsin Deficiency Had a Specific Patient Reported Outcome Measure? A Review.α-1抗胰蛋白酶缺乏症是否到了拥有特定患者报告结局指标的时候?一项综述。
Patient Relat Outcome Meas. 2025 Jan 15;16:23-35. doi: 10.2147/PROM.S490849. eCollection 2025.
3
Targeting the Liver with Nucleic Acid Therapeutics for the Treatment of Systemic Diseases of Liver Origin.
针对肝脏的核酸治疗药物用于治疗肝脏起源的系统性疾病。
Pharmacol Rev. 2023 Dec 15;76(1):49-89. doi: 10.1124/pharmrev.123.000815.
4
Disease burden associated with alpha-1 antitrypsin deficiency: systematic and structured literature reviews.与α-1 抗胰蛋白酶缺乏症相关的疾病负担:系统和结构化文献回顾。
Eur Respir Rev. 2022 Mar 23;31(163). doi: 10.1183/16000617.0262-2021. Print 2022 Mar 31.
5
Defects in Protein Folding and/or Quality Control Cause Protein Aggregation in the Endoplasmic Reticulum.内质网中蛋白质折叠和/或质量控制缺陷导致蛋白质聚集。
Prog Mol Subcell Biol. 2021;59:115-143. doi: 10.1007/978-3-030-67696-4_6.